European Union (Withdrawal) Bill

Debate between Lord Wallace of Saltaire and Baroness Chalker of Wallasey

Committee: 8th sitting (Hansard - continued): House of Lords
Monday 19th March 2018 Lords Chamber

[Lord Wallace of Saltaire]

Shortly after the referendum, I was sitting in the orthopaedic surgeon’s office with my wife, who was about to have a new hip, and he explained to us how leaving the European Union would cost the NHS more and would make it more difficult for him to procure what, in his opinion, was the best artificial hip available for the occasion. It was made by a multinational company in southern Ireland with bits—as noble Lords will know, these are complicated devices—coming from across the border and various other places. This undoubtedly would be more expensive, take longer and cost the NHS more. It is yet another example of where, despite the false promises of how much money would flow into the NHS, it will actually be completely the other way round. We will be creating artificial obstacles of one sort or another for these artificial devices, which will affect us all extremely closely. Those of your Lordships who have not yet got one will probably get one within the next 10 years. As the noble Lord says, we are absolutely shooting ourselves in various different embarrassing places by accepting that, in leaving the European Union, we are making these possibilities more difficult and more expensive.

[Baroness Chalker of Wallasey (Con)]

My Lords, I hesitate to join in, as I have to declare a double interest. As many of your Lordships will remember, I witnessed Second Reading sitting just in front of the Throne in my surgical socks.

I have every sympathy with the amendment proposed by the noble Lord, Lord Empey, and particularly with the speech of my noble friend Lord Deben. There is absolutely no doubt that the pioneering spirit, particularly in orthopaedics, in this country has been of immense value. It is not that other countries within the EU do not have their experts—of course they do—but there has been, as I will say in a later debate, a very special dedication in this country to improving health, not only for this nation but for our partners in the EU and partners far more widely across the world. It therefore behoves us to make sure that we have, in any arrangements, the opportunity for those British companies that have been such pioneers and indeed such income earners for Britain not only to pursue their existing research but to collaborate with the partners that they have engendered and encouraged in many other parts of the world.

I hope when my noble friend replies that he realises that this is far wider than just your Lordships’ personal interests. It goes right across the world, and what is done here can be replicated for the benefit of Britain, in or out of the EU. But we must be able to continue to give that information freely and for it to be accepted within the EU. That is the concern that many people have: that, if and when we leave the EU, much of that brilliant innovation will be lost to other partners and other parts of the world.